149 related articles for article (PubMed ID: 27341781)
21. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
[TBL] [Abstract][Full Text] [Related]
23. The structure-based optimization of δ-sultone-fused pyrazoles as selective BuChE inhibitors.
Zhang Z; Min J; Chen M; Jiang X; Xu Y; Qin H; Tang W
Eur J Med Chem; 2020 Sep; 201():112273. PubMed ID: 32569925
[TBL] [Abstract][Full Text] [Related]
24. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors.
Skrzypek A; Matysiak J; Niewiadomy A; Bajda M; Szymański P
Eur J Med Chem; 2013 Apr; 62():311-9. PubMed ID: 23376249
[TBL] [Abstract][Full Text] [Related]
26. Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity.
Mao F; Chen J; Zhou Q; Luo Z; Huang L; Li X
Bioorg Med Chem Lett; 2013 Dec; 23(24):6737-42. PubMed ID: 24220172
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, docking study and biological evaluation of some novel tetrahydrochromeno [3',4':5,6]pyrano[2,3-b]quinolin-6(7H)-one derivatives against acetyl- and butyrylcholinesterase.
Khoobi M; Alipour M; Moradi A; Sakhteman A; Nadri H; Razavi SF; Ghandi M; Foroumadi A; Shafiee A
Eur J Med Chem; 2013 Oct; 68():291-300. PubMed ID: 23988412
[TBL] [Abstract][Full Text] [Related]
28. Ionic liquid mediated synthesis of mono- and bis-spirooxindole-hexahydropyrrolidines as cholinesterase inhibitors and their molecular docking studies.
Kia Y; Osman H; Kumar RS; Basiri A; Murugaiyah V
Bioorg Med Chem; 2014 Feb; 22(4):1318-28. PubMed ID: 24461561
[TBL] [Abstract][Full Text] [Related]
29. Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer's Disease.
Okello EJ; Mather J
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326457
[TBL] [Abstract][Full Text] [Related]
30. Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-D-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors.
Bhakta HK; Park CH; Yokozawa T; Min BS; Jung HA; Choi JS
Arch Pharm Res; 2016 Jun; 39(6):794-805. PubMed ID: 27106028
[TBL] [Abstract][Full Text] [Related]
31. Amaryllidaceae Alkaloids of Belladine-Type from
Al Mamun A; Maříková J; Hulcová D; Janoušek J; Šafratová M; Nováková L; Kučera T; Hrabinová M; Kuneš J; Korábečný J; Cahlíková L
Biomolecules; 2020 May; 10(5):. PubMed ID: 32455879
[TBL] [Abstract][Full Text] [Related]
32. Interaction study of two diterpenes, cryptotanshinone and dihydrotanshinone, to human acetylcholinesterase and butyrylcholinesterase by molecular docking and kinetic analysis.
Wong KK; Ngo JC; Liu S; Lin HQ; Hu C; Shaw PC; Wan DC
Chem Biol Interact; 2010 Sep; 187(1-3):335-9. PubMed ID: 20350537
[TBL] [Abstract][Full Text] [Related]
33. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
[TBL] [Abstract][Full Text] [Related]
34. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors.
Shen Q; Peng Q; Shao J; Liu X; Huang Z; Pu X; Ma L; Li YM; Chan AS; Gu L
Eur J Med Chem; 2005 Dec; 40(12):1307-15. PubMed ID: 16182411
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the inhibitory effect of abamectin on mammalian butyrylcholinesterase: Enzyme kinetic and molecular docking studies.
Teralı K; Dalmizrak O; Hoti Q; Ozer N
J Environ Sci Health B; 2018; 53(11):713-718. PubMed ID: 29883250
[TBL] [Abstract][Full Text] [Related]
38. Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.
Castro MJ; Richmond V; Romero C; Maier MS; Estévez-Braun A; Ravelo AG; Faraoni MB; Murray AP
Bioorg Med Chem; 2014 Jul; 22(13):3341-50. PubMed ID: 24835788
[TBL] [Abstract][Full Text] [Related]
39. 2-(2-indolyl-)-4(3H)-quinazolines derivates as new inhibitors of AChE: design, synthesis, biological evaluation and molecular modelling.
Li Z; Wang B; Hou JQ; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):583-92. PubMed ID: 22380775
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies.
Kumar J; Meena P; Singh A; Jameel E; Maqbool M; Mobashir M; Shandilya A; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2016 Aug; 119():260-77. PubMed ID: 27227482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
